SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-061496
Filing Date
2023-11-09
Accepted
2023-11-09 06:44:46
Documents
14
Period of Report
2023-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sybx-20231109.htm   iXBRL 8-K 49700
2 EX-99.1 sybx-ex99_1.htm EX-99.1 193832
3 GRAPHIC img56602281_0.jpg GRAPHIC 135541
  Complete submission text file 0000950170-23-061496.txt   562061

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sybx-20231109_lab.xml EX-101.LAB 19083
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sybx-20231109.xsd EX-101.SCH 2480
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sybx-20231109_pre.xml EX-101.PRE 12004
8 EXTRACTED XBRL INSTANCE DOCUMENT sybx-20231109_htm.xml XML 4872
Mailing Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET SUITE 402 CAMBRIDGE MA 02142 617-401-9975
SYNLOGIC, INC. (Filer) CIK: 0001527599 (see all company filings)

IRS No.: 261824804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37566 | Film No.: 231389946
SIC: 2834 Pharmaceutical Preparations